Efter subkutan administration af en enkelt 40 mg dosis var absorption og distribution af adalimumab langsom, og maksimal serumkoncentration blev nået omkring 5 dage efter administration.
After subcutaneous administration of a single 40 mg dose, absorption and distribution of adalimumab was slow, with peak serum concentrations being reached about 5 days after administration.